1 February
2024
Assura plc
Total Voting
Rights
In conformity with the FCA's
Disclosure Guidance and Transparency Rules DTR 5.6.1 we hereby
notify that the company's issued share capital consists
of:
Issued shares and voting
rights
2,984,790,496 ordinary shares of 10 pence each
("Shares")
The above figure of 2,984,790,496
shares may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, shares
of Assura plc under the FCA's Disclosure and Transparency Rules. No
shares are held in treasury.
- Ends
-
For more information, please
contact:
|
Assura plc
|
Tel: 0161 515 2043
|
|
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
|
FGS
Global
Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is a national healthcare
premises specialist and UK REIT based in Altrincham, UK - caring
for more than 600 primary healthcare buildings, from which over six
million patients are served.
A constituent of the FTSE 250 and
the EPRA* indices, as at 30 September 2023, Assura's portfolio was
valued at £2.7 billion.
At Assura, we BUILD for health.
Assura builds better spaces for people and places, invests in
skills and inspires new ways of working, and unlocks the power of
design and innovation to deliver lasting impact for communities -
aiming for six million people to have benefitted from improvements
to and through its healthcare buildings by 2026.
Assura is leading for a sustainable
future, targeting net zero carbon across its portfolio by
2040.
Further information is available
at www.assuraplc.com
*EPRA is a
registered trademark of the European Public Real Estate
Association
Assura plc LEI code: 21380026T19N2Y52XF72